Abstract: N/A
FORM - 2
The Patent Act, 1970
(39 of 1970)
(section 10 Rule 13}
1) METHOD OF PRODUCING
HOMEOPATHIC PREPARATION OF A
MICRO DOSI OF POTINTIZED
HYDROQUINONI FOR THE
TREATMENT OF VITILIGO .
2) DR RAJESH SHAH (Indian National),
having office at Life Force Center, 413,
Krushal Commercial Complex,. 4'" Floor, Above Shopper's Stop, M. G. Road, Ghahkopar (East), Mumbai - 400 089? India. .
The following specification particularly describes the nature of this invention & the manner in which it is performed:
1
The present invention relates to a method of producing homeopathic preparation of a micro doss of potentized Hydroquinone for the treatment of Vitiligo.
Vitiligo or Leucoderma is a disease in which the patient develops hypo pigmentation of skin. It is a disorder which mainly concerns the melanin- formation of the skin. The skin develops white patches which may increase with time; and in the absence of proper and timely treatment, these white patches may spread over to other parts of the body.
There is no conventional method comparable to the present invention since Hydroquinone has never been used in medical history for the treatment of Vitiligo or hypo pigmented spots. Further, Hydroquinone has never been used orally, as it is poisonous when taken in crude form.
The medication prepared by the present method has been developed with certain objectives which are explained below,
The medication prepared by the present method should be effective against Vitiligo or hypo pigmented spots and should help the skin gain back its normal colour.
Also, the medication prepared by the present method should be free from side effects and not cause any harm to the patient.
The present invention will now be described in detail as follows.
A milligram of Hydroquinone (formula; C6H602) is mixed with 99 parts of distilled water (or alcohol) in one dram size vial. (Hydroquinone is a chemical whose synonyms are hydroquinoi, quinol, p-benzenediol, 1,4-benzenediol, p-dihydroxybenzene, p-hydroxy phenol, 1,4-dihydroxyhenzene, dihydroquinone, arctiivin, phiaquin, tecquinol, tenox HQ, tequinol). It is thoroughly shaken and 15 powerful strokes are administered with a mechanical device. This mechanical process of administering strokes is called potentisation in the science of homeopathy. The liquid thus prepared is labeled as Hydroquinone 1 o (which means Hydroquinone with 1 o potency).
Now approximately 1 millilitre of the liquid produced (i.e. Hydroquinone 1 c) is mixed
with 99 parts of distilled water (or alcohol) in another vial to undergo potentisation with about 15 powerful mechanical strokes to arrive to Hydroquinone 2 c potency. Likewise, the procedure is repeated to reach to 3 c, 4 c, 30 c, 50 c, 100 c, 1000 c, 5000 c, upto 5 million c potencies. The medicines prepared are called as Hydroquinone lc, Hydroquinone 2c, etc. upto Hydroquinone 5 million c.
It may be noted that the proportion of Hydroquinone to water (or alcohol) can be varied from 1 ; 99 to 50 i 50. This new homoeopathic preparation is administered orally.
The present invention has many advantages some of which are mentioned below.
The medication prepared by the present method can be used for the treatment of Vitiligo (Lencoderma) or hypo pigmentation of skin. This medication is found to be very effective agaiast vitiligo or hypo pigmented spots. It seems to stimulate the melanin (pigment) mechanism and helps induce normal coloration to skin, which is called as regimentation.
Further, the medication prepared by the present method is completely harmless and free from side effects since Hydroquinone is used in a micro dose.
-3-
1 CLAIM ;-
1) A method of producing homeopathic preparation of a micro dose of potentized
Hydroquinone for the treatment of Vitiligo in which 1 milligram of Hydroquinone and
99 parts of distilled water (for alcohol) are mixed in one dram size vial, thoroughly
shaken and 15 powerful strokes are administered with a mechanical device to .give
Hydroquinone 1 c, about 1 milliliter of which is then mixed with 99 parts of distilled
water (or alcohol) in another vial with about 15 powerful mechanical strokes to arrive to
Hydroquinone 2 c potency; and the said procedure is repeated likewise to reach to
Hydroquinone 3 c, Hydroquinone 4 c upto Hydroquinone 5 million c potencies; in
which the proportion of Hydroquinone to water (or alcohol) can be varied from 1 ; 99 to 30 : 50 depending upon the intensity of the disease; and the homeopathic preparation
so produced is administered orally.
2) The method as claimed in claim 1 in which 1 milligram of Hydroquinone (formula: C6H602) is mixed with 99 parts of distilled water (or alcohol in one dram size vial.
3) The method as claimed in claims 1 and 2 in which the said mixture is thoroughly shaken and 15 powerful strokes are administered with a mechanical device; this mechanical process of administering strokes is called potentisation.
4) The method as claimed in claims 1 to 3 in which the liquid thus prepared is labeled as Hydroquinone 1 c (which means Hydroquinone with 1 c potency).
5) The method as claimed in claims 1 to 4 in which approximately 1 milliliter of the liquid produced (i.e. Hydroquinone 1 c) is mixed with 99 parts of distilled water (or alcohol) in another vial to undergo potentisation with about 15 powerful mechanical strokes to arrive to Hydroquinone 2 c potency.
6) The method as claimed in claims 1 to 5 in which the potentisation procedure is repeated to reach to 3 c, 4 c, 30 c, 50 c, 100 c, 1000 c, 5000 c, upto 5 million c potencies: the
medicines prepared are called as Hydroquinone lc, Hydroquinone 2cf etc, upto Hydroquinone 5 million c.
7) The method as claimed in claims 1 to 6 in which the proportion of Hydroquinone to water (or alcohol) can be varied from 1 : 99 to 50 : 50.
8) The method as claimed in claim i in which the homeopathic medication produced is
administered orally.
9) The method as claimed in claim 1 and 8 in which Hydiroquinone is a chemical whose
synonyms are hydrequinol, quinoI p-benzenediol, I,4-benzenedioI p-
dihydroxybenzene, p-hydroxyphenol, 1,4=dihydroxybenzsn8, dihydroquinone, arctuvin, phiaquin tecquinoi tenox HQS tequinol.
Dated 24 TH day of December 2003
JOSEPH VARIKASERY OF VARIKASERY & VARIKASERY
Agent for the applicant
-5-
| # | Name | Date |
|---|---|---|
| 1 | 8-mum-2004-form 3(21-12-2003).pdf | 2003-12-21 |
| 1 | 8-MUM-2004-FORM-27 [25-09-2024(online)].pdf | 2024-09-25 |
| 2 | 8-MUM-2004-CORRESPONDENCE-(02-01-2014).pdf | 2014-01-02 |
| 2 | 8-MUM-2004-RELEVANT DOCUMENTS [01-10-2023(online)].pdf | 2023-10-01 |
| 3 | Form 27 [28-03-2017(online)].pdf | 2017-03-28 |
| 3 | 8-MUM-2004-RELEVANT DOCUMENTS [26-12-2022(online)].pdf | 2022-12-26 |
| 4 | 8-MUM-2004-SPECIFICATION(AMENDED)-(10-6-2004).pdf | 2018-08-09 |
| 4 | 8-MUM-2004-PETITION UNDER RULE 137 [21-12-2022(online)].pdf | 2022-12-21 |
| 5 | 8-MUM-2004-RELEVANT DOCUMENTS [29-09-2021(online)].pdf | 2021-09-29 |
| 5 | 8-mum-2004-power of attorney(5-1-2004).pdf | 2018-08-09 |
| 6 | 8-MUM-2004-RELEVANT DOCUMENTS [17-03-2020(online)].pdf | 2020-03-17 |
| 6 | 8-MUM-2004-FORM 26(31-7-2006).pdf | 2018-08-09 |
| 7 | 8-MUM-2004-RELEVANT DOCUMENTS [01-04-2019(online)].pdf | 2019-04-01 |
| 7 | 8-mum-2004-form 26(28-6-2006).pdf | 2018-08-09 |
| 8 | 8-mum-2004-form 2(title page)-(granted)-(23-8-2006).pdf | 2018-08-09 |
| 9 | 8-mum-2004-abstract(5-1-2004).pdf | 2018-08-09 |
| 9 | 8-MUM-2004-FORM 2(TITLE PAGE)-(5-1-2004).pdf | 2018-08-09 |
| 10 | 8-mum-2004-abstract(granted)-(23-8-2006).pdf | 2018-08-09 |
| 10 | 8-mum-2004-form 2(granted)-(5-1-2004).pdf | 2018-08-09 |
| 11 | 8-MUM-2004-CANCELLED PAGES(24-2-2005).pdf | 2018-08-09 |
| 12 | 8-mum-2004-cancelled pages(25-2-2005).pdf | 2018-08-09 |
| 12 | 8-mum-2004-form 2(granted)-(23-8-2006).pdf | 2018-08-09 |
| 13 | 8-MUM-2004-CLAIMS(5-1-2004).pdf | 2018-08-09 |
| 13 | 8-MUM-2004-FORM 2(COMPLETE)-(5-1-2004).pdf | 2018-08-09 |
| 14 | 8-MUM-2004-CLAIMS(AMENDED)-(24-2-2005).pdf | 2018-08-09 |
| 14 | 8-mum-2004-form 19(5-1-2004).pdf | 2018-08-09 |
| 15 | 8-MUM-2004-CLAIMS(AMENDED)-(25-2-2005).pdf | 2018-08-09 |
| 15 | 8-mum-2004-form 13(31-7-2006).pdf | 2018-08-09 |
| 16 | 8-mum-2004-claims(granted)-(23-8-2006).pdf | 2018-08-09 |
| 16 | 8-mum-2004-form 1(5-1-2004).pdf | 2018-08-09 |
| 17 | 8-mum-2004-form 1(24-2-2005).pdf | 2018-08-09 |
| 18 | 8-mum-2004-form 1(10-6-2004).pdf | 2018-08-09 |
| 18 | 8-mum-2004-claims(granted)-(5-1-2004).pdf | 2018-08-09 |
| 19 | 8-mum-2004-correspondence 1(28-7-2006).pdf | 2018-08-09 |
| 19 | 8-mum-2004-description(granted)-(23-8-2006).pdf | 2018-08-09 |
| 20 | 8-mum-2004-correspondence 2(24-2-2005).pdf | 2018-08-09 |
| 20 | 8-MUM-2004-DESCRIPTION(COMPLETE)-(5-1-2004).pdf | 2018-08-09 |
| 21 | 8-mum-2004-correspondence(ipo)-(23-8-2006).pdf | 2018-08-09 |
| 21 | 8-MUM-2004-CORRESPONDENCE(IPO)-(3-11-2006).pdf | 2018-08-09 |
| 22 | 8-mum-2004-correspondence(ipo)-(23-8-2006).pdf | 2018-08-09 |
| 22 | 8-MUM-2004-CORRESPONDENCE(IPO)-(3-11-2006).pdf | 2018-08-09 |
| 23 | 8-mum-2004-correspondence 2(24-2-2005).pdf | 2018-08-09 |
| 23 | 8-MUM-2004-DESCRIPTION(COMPLETE)-(5-1-2004).pdf | 2018-08-09 |
| 24 | 8-mum-2004-description(granted)-(23-8-2006).pdf | 2018-08-09 |
| 24 | 8-mum-2004-correspondence 1(28-7-2006).pdf | 2018-08-09 |
| 25 | 8-mum-2004-claims(granted)-(5-1-2004).pdf | 2018-08-09 |
| 25 | 8-mum-2004-form 1(10-6-2004).pdf | 2018-08-09 |
| 26 | 8-mum-2004-form 1(24-2-2005).pdf | 2018-08-09 |
| 27 | 8-mum-2004-claims(granted)-(23-8-2006).pdf | 2018-08-09 |
| 27 | 8-mum-2004-form 1(5-1-2004).pdf | 2018-08-09 |
| 28 | 8-MUM-2004-CLAIMS(AMENDED)-(25-2-2005).pdf | 2018-08-09 |
| 28 | 8-mum-2004-form 13(31-7-2006).pdf | 2018-08-09 |
| 29 | 8-MUM-2004-CLAIMS(AMENDED)-(24-2-2005).pdf | 2018-08-09 |
| 29 | 8-mum-2004-form 19(5-1-2004).pdf | 2018-08-09 |
| 30 | 8-MUM-2004-CLAIMS(5-1-2004).pdf | 2018-08-09 |
| 30 | 8-MUM-2004-FORM 2(COMPLETE)-(5-1-2004).pdf | 2018-08-09 |
| 31 | 8-mum-2004-cancelled pages(25-2-2005).pdf | 2018-08-09 |
| 31 | 8-mum-2004-form 2(granted)-(23-8-2006).pdf | 2018-08-09 |
| 32 | 8-MUM-2004-CANCELLED PAGES(24-2-2005).pdf | 2018-08-09 |
| 33 | 8-mum-2004-abstract(granted)-(23-8-2006).pdf | 2018-08-09 |
| 33 | 8-mum-2004-form 2(granted)-(5-1-2004).pdf | 2018-08-09 |
| 34 | 8-mum-2004-abstract(5-1-2004).pdf | 2018-08-09 |
| 34 | 8-MUM-2004-FORM 2(TITLE PAGE)-(5-1-2004).pdf | 2018-08-09 |
| 35 | 8-mum-2004-form 2(title page)-(granted)-(23-8-2006).pdf | 2018-08-09 |
| 36 | 8-mum-2004-form 26(28-6-2006).pdf | 2018-08-09 |
| 36 | 8-MUM-2004-RELEVANT DOCUMENTS [01-04-2019(online)].pdf | 2019-04-01 |
| 37 | 8-MUM-2004-RELEVANT DOCUMENTS [17-03-2020(online)].pdf | 2020-03-17 |
| 37 | 8-MUM-2004-FORM 26(31-7-2006).pdf | 2018-08-09 |
| 38 | 8-MUM-2004-RELEVANT DOCUMENTS [29-09-2021(online)].pdf | 2021-09-29 |
| 38 | 8-mum-2004-power of attorney(5-1-2004).pdf | 2018-08-09 |
| 39 | 8-MUM-2004-SPECIFICATION(AMENDED)-(10-6-2004).pdf | 2018-08-09 |
| 39 | 8-MUM-2004-PETITION UNDER RULE 137 [21-12-2022(online)].pdf | 2022-12-21 |
| 40 | Form 27 [28-03-2017(online)].pdf | 2017-03-28 |
| 40 | 8-MUM-2004-RELEVANT DOCUMENTS [26-12-2022(online)].pdf | 2022-12-26 |
| 41 | 8-MUM-2004-CORRESPONDENCE-(02-01-2014).pdf | 2014-01-02 |
| 41 | 8-MUM-2004-RELEVANT DOCUMENTS [01-10-2023(online)].pdf | 2023-10-01 |
| 42 | 8-mum-2004-form 3(21-12-2003).pdf | 2003-12-21 |
| 42 | 8-MUM-2004-FORM-27 [25-09-2024(online)].pdf | 2024-09-25 |